The application discloses a
system, device or medium for diagnosing or predicting Alzheimer's
disease based on a
gene marker combination, and belongs to the technical field of tumor markers. The
gene marker combination comprises TMEM74, CBLN4, SYDE2, SLFNL1, PITPNM3, MPPED1, SYNDIG1L,
ADAMTS5, BMX, GLUL, KRT79, TULP2, PRSS16, IL25, KCNJ16, SLC22A25, CRYAA, DLX2, SHISA6, CRYGA, EFCAB3, GMFB, RIN1, DMRTA1, CER1, CYP26B1, REG3A, HTRA3, SLC2A4, CRYGB and SOX3. The expression
level data of the
gene marker combination are used to construct a
machine learning model, which can be used to diagnose whether a subject has Alzheimer's
disease or predict whether a subject has a risk of suffering from Alzheimer's
disease, and has great clinical application value.